Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
Open Access
- 17 January 2005
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 35 (5), 509-513
- https://doi.org/10.1038/sj.bmt.1704828
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Adverse Reactions to VoriconazoleClinical Infectious Diseases, 2004
- Determination of Vitreous, Aqueous, and Plasma Concentration of OrallyAdministered Voriconazole in HumansArchives of Ophthalmology (1950), 2004
- In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2003
- Voriconazole Concentrations in the Cerebrospinal Fluid and Brain Tissue of Guinea Pigs and Immunocompromised PatientsClinical Infectious Diseases, 2003
- Development and Validation of a High-Performance Liquid Chromatography Assay for VoriconazoleAntimicrobial Agents and Chemotherapy, 2003
- Voriconazole: A New Triazole Antifungal AgentClinical Infectious Diseases, 2003
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation RegimensAntimicrobial Agents and Chemotherapy, 2002
- Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000Antimicrobial Agents and Chemotherapy, 2002
- Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent FeverNew England Journal of Medicine, 2002